| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.25 | 0.05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |